Literature DB >> 23962653

Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Samer N Arafat1, Ana M Suelves2, Sandra Spurr-Michaud3, James Chodosh4, C Stephen Foster5, Claes H Dohlman4, Ilene K Gipson6.   

Abstract

OBJECTIVE: To investigate the levels of matrix metalloproteinases (MMPs), myeloperoxidase (MPO), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in tears of patients with Stevens-Johnson syndrome (SJS) and ocular cicatricial pemphigoid (OCP).
DESIGN: Prospective, noninterventional cohort study. PARTICIPANTS: Four SJS patients (7 eyes), 19 OCP patients (37 eyes), and 20 healthy controls who underwent phacoemulsification (40 eyes).
METHODS: Tear washes were collected from all patients and were analyzed for levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 using multianalyte bead-based enzyme-linked immunosorbent assays. Total MMP activity was determined using a fluorometric assay. Correlation studies were performed between the various analytes within study groups. MAIN OUTCOME MEASURES: Levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 (in nanograms per microgram of protein) and total MMP activity (in relative fluorescent units per minute per microgram of protein) in tears; MMP-8-to-TIMP-1 ratio; MMP-9-to-TIMP-1 ratio; and the correlations between MMP-8 and MMP-9 and both MMP and MPO.
RESULTS: MMP-8, MMP-9, and MPO levels were elevated significantly in SJS and OCP tears (SJS>OCP) when compared with controls. The MMP activity was highest in SJS patients, whereas OCP patients and controls showed lower and similar activities. The TIMP-1 levels were decreased in SJS and OCP patients when compared with those in controls, with levels in OCP patients reaching significance. The MMP-8-to-TIMP-1 and MMP-9-to-TIMP-1 ratios were markedly elevated in SJS and OCP tears (SJS>OCP) when compared with those of controls. Across all study groups, MMP-9 levels correlated strongly with MMP-8 and MPO levels, and MMP-8 correlated with MPO, but it did not reach significance in SJS patients. There was no relationship between MMP-7 and MPO.
CONCLUSIONS: Because MMP-8 and MPO are produced by inflammatory cells, particularly neutrophils, the correlation data indicate that they may be the common source of elevated enzymes, including MMP-9, in SJS and OCP tears. Elevated MMP-to-TIMP ratios and MMP activity suggest an imbalance in tear MMP regulation that may explain the predisposition of these patients to demonstrate corneal melting and chronic complications associated with persistent inflammation. Myeloperoxidase in tears may be a sensitive and specific marker for the quantification of ocular inflammation.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23962653      PMCID: PMC3920830          DOI: 10.1016/j.ophtha.2013.06.049

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  44 in total

1.  Changes in the diurnal pattern of the distribution of gelatinases and associated proteins in normal and pathological tear fluids: evidence that the PMN cell is a major source of MMP activity in tear fluid.

Authors:  Robert A Sack; Sonal Sathe; Ann R Beaton; Bruce Bogart; George Lew
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 2.  Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment.

Authors:  Muna Ahmed; Ghassan Zein; Faizullah Khawaja; C Stephen Foster
Journal:  Prog Retin Eye Res       Date:  2004-11       Impact factor: 21.198

3.  Tear film MMP accumulation and corneal disease.

Authors:  V A Smith; H Rishmawi; H Hussein; D L Easty
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

4.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

5.  Episodic conjunctival inflammation after Stevens-Johnson syndrome.

Authors:  C S Foster; L P Fong; D Azar; K R Kenyon
Journal:  Ophthalmology       Date:  1988-04       Impact factor: 12.079

6.  Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases.

Authors:  H Saari; K Suomalainen; O Lindy; Y T Konttinen; T Sorsa
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

Review 7.  Chronic cicatrizing conjunctivitis.

Authors:  H G Faraj; T Hoang-Xuan
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

Review 8.  Hypochlorous acid and taurine-N-monochloramine in periodontal diseases.

Authors:  A Mainnemare; B Mégarbane; A Soueidan; A Daniel; I L C Chapple
Journal:  J Dent Res       Date:  2004-11       Impact factor: 6.116

9.  Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.

Authors:  Damian N Meli; Stephan Christen; Stephen L Leib
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

10.  Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.

Authors:  Andrea Leonardi; Paola Brun; Giovanni Abatangelo; Mario Plebani; Antonio G Secchi
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

View more
  23 in total

1.  Matrix Metalloproteinase-Deactivating Contact Lens for Corneal Melting.

Authors:  Chelsi Lopez; Shiwha Park; Seth Edwards; Selina Vong; Shujie Hou; Minyoung Lee; Hunter Sauerland; Jung-Jae Lee; Kyung Jae Jeong
Journal:  ACS Biomater Sci Eng       Date:  2019-01-04

Review 2.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

3.  Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency.

Authors:  Sophie X Deng; Vincent Borderie; Clara C Chan; Reza Dana; Francisco C Figueiredo; José A P Gomes; Graziella Pellegrini; Shigeto Shimmura; Friedrich E Kruse
Journal:  Cornea       Date:  2019-03       Impact factor: 2.651

4.  Cellular Uptake and Delivery of Myeloperoxidase to Lysosomes Promote Lipofuscin Degradation and Lysosomal Stress in Retinal Cells.

Authors:  Gouri Yogalingam; Amanda R Lee; Donald S Mackenzie; Travis J Maures; Agnes Rafalko; Heather Prill; Geoffrey Y Berguig; Chuck Hague; Terri Christianson; Sean M Bell; Jonathan H LeBowitz
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

5.  Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I.

Authors:  Marie-Claude Robert; Samer N Arafat; Sandra Spurr-Michaud; James Chodosh; Claes H Dohlman; Ilene K Gipson
Journal:  Cornea       Date:  2016-07       Impact factor: 2.651

6.  [Transplants from the hard palate: method for mucosal graft reconstruction of the upper eyelid].

Authors:  M Emesz; E M Krall; M Rasp; F M Bauer; G Grabner; E M Arlt
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

7.  Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.

Authors:  Takeshi Umazume; William M Thomas; Sabrina Campbell; Hema Aluri; Suharika Thotakura; Driss Zoukhri; Helen P Makarenkova
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  UV cross-linking of donor corneas confers resistance to keratolysis.

Authors:  Samer N Arafat; Marie-Claude Robert; Anita N Shukla; Claes H Dohlman; James Chodosh; Joseph B Ciolino
Journal:  Cornea       Date:  2014-09       Impact factor: 2.651

9.  Leukocyte Distribution in the Open Eye Tears of Normal and Dry Eye Subjects.

Authors:  Cameron K Postnikoff; Carrie Huisingh; Gerald McGwin; Kelly K Nichols
Journal:  Curr Eye Res       Date:  2018-08-09       Impact factor: 2.424

10.  Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.

Authors:  Hema S Aluri; Claire L Kublin; Suharika Thotakura; Helene Armaos; Mahta Samizadeh; Dillon Hawley; William M Thomas; Paul Leavis; Helen P Makarenkova; Driss Zoukhri
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.